Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

NCT03399110

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jiangsu Cancer Hospital Nanjing, China
View Trial Details
Active, Not Recruiting

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

NCT04005339

Conditions
Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Washington University School of Medicine- Siteman Cancer Center St Louis, Missouri, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

NCT04137107

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 793 locations
View Trial Details
Active, Not Recruiting

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04550481

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions